FindTrial
Sign In

Predictive nursing for gastrointetinal side effects of the radioiodine re-treatment in patients with differentiated thyroid cancer

Predictive nursing for gastrointetinal side effects of the radioiodine re-treatment in patients with differentiated thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034994
Enrollment
Unknown
Registered
2020-07-26
Start date
2017-01-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

differentiated

Interventions

Intervention group:Predictive nursing
Control group:Conventional nursing

Sponsors

First Affiliated Hospital of Ji'nan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 68 Years

Inclusion criteria

Inclusion criteria: The patient met the criteria of the expert consensus (2017 version) for the clinical path of I-131 treatment after differentiated thyroid cancer; DTC131I cleared metastatic and relapsed lesions (discharged) treatment patients; patients who needed 131I treatment again; informed and agreed to participate in this study.

Exclusion criteria

Exclusion criteria: Patients treated with I-131 thyroidectomy for the first time; those with surgical indications; those with unstable conditions.

Design outcomes

Primary

MeasureTime frame
Gastrointestinal reaction;Satisfy for the nursing;—

Countries

China

Contacts

Public ContactHao Xu

Department of Nuclear Medicine, First Affiliated Hospital of Ji'nan University

hao_xu2019@163.com+86 13392692189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026